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Fungal colonization in patients with chronic








Background: We screened patients with chronic respiratory diseases for microbiological and serological evidences
of fungal colonisation; in order to determine its prevalence in this group of patients, examine potential clinical and
radiological predictors of fungal colonisation and characterise fungal agents associated with individual diseases.
Methods: BAL samples from 60 consecutive patients were subjected to microscopy and culture for fungal agents.
Serum samples were analysed for precipitin antibodies to Aspergillus antigen and Candida cytoplasmic antigen.
Statistical significance in the difference of fungal recovery between patient groups was determined using the Chi-
square test.
Results: The major diagnostic groups included patients with bronchogenic carcinoma (n = 31) and tubercular
sequelae (n = 16). In all, 28 patients (46.7%) were culture-positive, with Candida and Aspergillus being recovered
from 14 and 13 patients respectively. Twenty-one patients (35%) showed presence of precipitin antibodies. Patients
with bronchogenic carcinoma showed increased predilection for colonisation with Aspergillus, while Candida was
recovered more commonly in tubercular sequelae (p = 0.02). There was no statistically significant association
between culture-positivity and specific risk factors/radiological findings.
Conclusion: The point-prevalence of fungal colonization was almost 50%. The combination of fungal culture and
serology helped improve diagnostic sensitivity. An interesting predilection was observed for Aspergillus and
Candida, to preferentially infect patients with Bronchogenic carcinoma and Tubercular sequelae respectively. In
absence of specific predictors, the possibility of fungal colonization needs to be explored actively in these patients.
Background
Fungal infections have emerged as a world-wide health
care problem in recent years [1], owing to the extensive
use of broad-spectrum antibiotics [2], long-term use of
immunosuppressive agents, increasing use of hyperali-
mentation and indwelling devices [3] and the increasing
population of terminally ill, debilitated and immuno-
compromised patients [4]. In tune with this general
trend, there has been a phenomenal rise in the occur-
rence of fungal lung infections over the last two decades
[5], a significant fraction of which is community-
acquired [1]. Specific diagnosis of fungal pneumonia
assumes importance in view of the different therapeutic
strategies involved and the higher mortality associated
with acute invasive fungal infection. Unfortunately, diag-
nosis of fungal respiratory infection is always difficult,
owing to the lack of pathognomonic clinical features,
contamination of the non-invasive samples like sputum
with normal commensal flora and difficulty in obtaining
invasive samples like translaryngeal aspirate and lung
biopsy. A previous study has shown that Candida colo-
nization could be found in the respiratory samples
obtained by Bronchoalveolar lavage (BAL), endotracheal
aspirate or protected specimenb r u s h i n gi nc r i t i c a l l yi l l
patients [6]. Since patients with chronic lung pathology
provide a suitable nidus for fungal colonization, we
hypothesized that screening such patients for fungal
colonization of the respiratory tract would enable us to
identify individuals requiring closer monitoring for the
development of possible complications like acute
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genous spread. The present study was designed with the
purpose of characterizing the fungal pathogens asso-
ciated with particular pulmonary diseases, and correlat-
ing between the individual fungal pathogens and the
profile of risk factors, radiological presentations and
clinical conditions in these patients.
Methods
Recruitment of patients and collection of clinical samples
The study extended over a period of 12 months and
included 60 consecutive patients with chronic lung dis-
eases who required bronchoscopic examination for diag-
nostic purposes. Patients suffering from active
Tuberculosis, pneumonitis and HIV-positive patients
were excluded. The study protocol was duly approved
by the institutional research and ethics committees.
Signed informed consent was obtained from all the
study participants.
Bronchoalveolar lavage (BAL) sample was collected
aseptically with the help off l e x i b l eb r o n c h o s c o p e
(Olympus Corporation; BF type TE2), attached to a light
source (Olympus CLK-4) and d i g i t a ls i g n a lp r o c e s s i n g
camera. The selection of the site for collection of BAL
fluid was guided by prior imaging studies and local
inspection of the disease site. As advocated by Jourdain
et al no endobronchial suction was attempted during
the advancement of the bronchoscope to avoid contami-
nation with upper airway flora and the first two aliquots
were discarded [7]. The BAL fluid was collected in a
sterile container and transported immediately to the
mycology laboratory. None of the patients had received
antibiotics for at least 2 weeks prior to the collection of
BAL fluid. Serum samples were also collected from the
same patients and stored at -20°C for serological
analysis.
Mycological processing
Centrifuged deposits prepared from BAL samples were
used for direct microscopy and culture on Sabouraud’s
dextrose agar (SDA) with and without antibiotics and
Czapek Dox Agar. The clinical significance of these iso-
lates were determined by ensuring that contamination
with oral flora had not taken place during sampling and
by correlating the culture record with observation made
during direct microscopy. Moreover, the growth was
considered to be significant only when the same fungal
agent was isolated from the different culture tubes.
The significant fungal isolates recovered on culture
were identified to the species level, using standard
mycological procedures. For Candida sp.i s o l a t e s ,t h e
tests performed included germ tube test, Dalmau culture
plate, sugar assimilation and fermentation tests and
ChromAgar. Identification of Aspergillus sp.w a sd o n e
by examining the colony morphology and microscopic
morphology of wet mounts prepared from the fungal
growth, before and after slide culture examination.
Cryptococcus neoformans was identified by characteristic
colony morphology, India ink preparation
Immunodiffusion test with Candida and Aspergillus
antigens
For immunodiffusion tests, Aspergillus antigen and anti-
sera were commercially procured (Adaltis Inc, Italy) and
Candida cytoplasmic antigen and corresponding antisera
were kindly provided by Prof. Arunaloke Chakrabarti,
Deptt of Medical Microbiology, Post Graduate Institute
of Medical Education & Research, Chandigarh, India.
Double diffusion test was done at 25°C by Oudin-Ouch-
terlony’s agar gel diffusion method and the immunodif-
fusion plates were observed for a week to detect the
presence of precipitin bands. On appearance, the preci-
pitin bands were stained in amido black solution.
Statistical analysis
The Chi-square test was used to examine if there was
statistically significant difference in the fungal recovery
rates between patients belonging to different diagnostic
categories and having different co-morbid conditions or
risk factors. Chi-square test was also used to analyse
possible association between fungal recovery and specific
radiological findings in Chest X-ray. Yates’ corrected
Chi-square test was employed to analyse differences in
the nature of fungal isolates recovered from patients
with Bronchogenic carcinoma and tubercular sequelae.
Results
Clinical profile of patients
The study group comprised of a total of 60 patients
(44 males) with ages ranging from 40 to 85 years (med-
ian age being 55 years). Thirty one patients (51.7%) pre-
sented with bronchogenic carcinoma, while 16 patients
(26.7%) had tubercular sequelae like persisting cavity,
collapse, fibrosis, etc. Among the different co-morbid
conditions and risk factors, the common associations
included diabetes mellitus (DM), severe anaemia (Hb
<9%), use of steroids, alcoholism and chronic carrier
state of HBV. While 10 patients had normal chest
X-ray, radiological abnormalities were detected in
50 patients, with consolidation (n = 10), collapse (n = 9)
and nodular lesion (n = 8) being the common findings.
Recovery of fungal agents
Direct microscopic examination revealed the presence of
septate hyphae with dichotomous branching in 10
patients and budding yeast cells in 11 patients. Fungal
culture yielded Aspergillus sp. in 13 patients (including
A. flavus in 6 patients, A. fumigatus in 4 patients and A.
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and C. tropicalis being isolated from 12 and 2 patients
respectively). One patient, with chronic interstitial lung
disease, showed growth of Cryptococcus neoformans.
The distribution of the fungal isolates with respect to
t h ed i a g n o s t i cg r o u p si sr e p r e s e n t e di nT a b l e1 .I na l l ,
28 patients (46.7%) were culture-positive.
Detection of anti-fungal precipitin antibodies
Twenty one of the recruited patients (35%) reacted posi-
tively in the immunodiffusion assays. Of the 13 and
14 patients who showed growth of Aspergillus sp.a n d
Candida sp. in their BAL samples, 7 (53.8%) and 8
(57.1%) patients respectively were positive for the corre-
sponding anti-fungal antibodies in the immunodiffusion
assay. Similarly among the serum samples from 47 and
46 culture-negative patients, 45 (95.7%) and 42 (91.3%)
patients respectively were found to be negative for preci-
pitin antibodies. Hence, taking culture as the gold stan-
dard, immunodiffusion had a sensitivity of 53.8% and a
specificity of 95.7%. The positive and negative predictive
values of immunodiffusion assay were 77.7% and 88.2%
respectively. The corresponding figures for detection of
anti-Candida antibodies were 57.1%, 91.3%, 66.7% and
87.5% respectively.
Correlation of microbiological and serological evidences
of fungal infection
In all, 15 of the 27 culture-positive patients (55.5%) were
also positive in immunodiffusion tests and culture-posi-
tivity, in absence of precipitin antibodies, was observed
in 12 patients. Eight of these 12 patients had co-morbid
immunosuppressive factors, like DM (3 patients), cancer
chemotherapy (2 patients), steroid use (1 patient),
chronic renal failure (1 patient) and chronic carriage of
HBV (I patient). Six patients were positive for precipitin
bands, despite being culture-negative. Interestingly, 5 of
these 6 patients had bronchogenic carcinoma, while the
sixth patient had pleural effusion of unresolved aetiology
(Table 2).
Clinical and radiological associates of fungal infection
We next analysed whether the incidence of fungal colo-
nization in the recruited patients had any association
with their clinical condition, presence of specific risk
factors or radiological findings. Though the difference in
culture-positivity rates between patients with Broncho-
genic carcinoma and tubercular sequelae was statistically
non-significant (p = 0.4), the nature of fungal isolates
were different between the two clinical conditions.
Among patients with Bronchogenic carcinoma, 8
patients showed growth of Aspergillus sp. while Candida
sp. was recovered from 2. In contrast, among patients
with tubercular sequelae, Candida sp. was recovered
from 6 patients while only a single patient showed
growth of Aspergillus sp. This difference in the nature of
fungal pathogens recovered from patients with Broncho-
genic carcinoma and tubercular sequelae was statistically
significant (p = 0.02; Yates’ corrected Chi-square test).
Diabetes mellitus was found to be the commonest risk
factor associated with the isolation of Candida albicans.
Out of 12 patients having Candida albicans as a fungal
isolate, 5 were having diabetes mellitus as a predisposing
factor (Table 3). However, there was no statistically
Table 1 Recovery of fungal agents with respect to clinical diagnosis
Clinical Diagnosis No. of patients Culture +ve patients (%) Isolates No. of Isolates (%)
Bronchogenic carcinoma 31 10 (32.3) A. flavus 5 (16.1)
C. albicans 2 (6.4)
A. niger 2 (6.4)
A. fumigatus 1 (3.2)
Tubercular sequelae 16 7 (43.8) C. albicans 5 (31.3)
C. tropicalis 1 (6.3)
A. fumigatus 1 (6.3)
Bronchiectasis 5 5 (100) C. albicans 3(60)
A. flavus 1 (20)
A. fumigatus 1 (20)
Pleural effusion 2 1 (50) A. niger 1 (50)
Bronchial asthma 2 2 (100) C. albicans 1 (50)
A. fumigatus 1 (50)
COPD 3 2 (66.7) C. albicans 1 (33.3)
C. tropicalis 1 (33.3)
Interstitial lung disease 1 1(100) C. neoformans 1(100)
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presence of any risk factor (p = 0.5). There was no dif-
ference, as well, in the fungal recovery rates between
male and female patients. Similarly, none of the radiolo-
gical patterns showed significantly higher association
with fungal recovery (p = 0.7). Interestingly, even nor-
mal chest radiography was associated with fungal
growth in 5 of the 10 patients. The growth of Cryptococ-
cus neoformans was associated with reticulo-nodular
lesion on chest radiography (Table 4).
Discussion
The literature is replete with reports of fungal lung
infections occurring in the background of overtly immu-
nocompromising conditions like transplantation, haema-
tological malignancy, neutropenia and HIV/AIDS.
Though several authors have examined the incidence of
infection with specific fungal agents in the context of
chronic lung pathology, studies on pulmonary mycoses,
as a group, have been relatively limited. In this study we
report the profile of fungal colonization of the respira-
tory tract in patients presenting with different chronic
respiratory conditions in a tertiary care teaching hospital
located in the Himalayan region of India. We observe
that 46.7% of the patients recruited in our study were
culture-positive for fungal agents and 35% demonstrated
presence of anti-fungal precipitin antibodies. Fungal
colonization was irrespective of the underlying lung
pathology and could not be predicted by the presence of
any specific co-morbid condition, risk factor or radiolo-
gical presentation. Moreover, a normal chest X-ray
could not be used to exclude the possibility of accompa-
nying pulmonary fungal infection. Interestingly, the
identity of the fungi recovered was different between the
major diagnostic categories with significant predilection
being observed for colonisation with Aspergillus sp.i n
patients suffering from Bronchogenic carcinoma and for
Candida sp. among patients with Tubercular sequelae.
Though it is difficult to make a confirmed distinction
between fungal colonisation of the lung and active fun-
gal infection [1], we considered our patients to be colo-
nised since none of our patients satisfied the criteria for
“proven”, “probable” or “possible” Invasive Fungal Dis-
ease, as proposed in the revised definitions of invasive
fungal disease from the European Organization for
Research and Treatment of Cancer/Invasive Fungal
Infections Cooperative Group and the National Institute
of Allergy and Infectious Diseases Mycoses Study Group
(EORTC/MSG) Consensus Group [8]. None of these
patients showed any radiological abnormality which
could not be explained by their underlying lung pathol-
ogy. Further follow-up study on patient progress is
Table 2 Results of Immunodiffusion assay for fungus-specific antibodies
Results of Immnodiffusion assay Culture positive Culture negative Total
Aspergillus-specific antibodies Immunodiffusion positive 7 2 9
Immunodiffusion negative 6 45 51
Total 13 47 60
Candida-specific Antibodies Immunodiffusion positive 8 4 12
Immunodiffusion negative 6 42 48
Total 14 46 60
Table 3 Recovery of fungal agents with respect to different risk factors
Co-morbid conditions/risk factors No. of patients Culture +ve patients (%) Isolates No. of Isolates (%)
Diabetes mellitus 7 5 (71.4) C. albicans 5 (71.4)
Steroid use 3 2 (66. 7) C. albicans 1 (33.3)
A. flavus 1 (33.3)
Chronic carrier HBV 3 2 (66. 7) A. flavus 1 (33.3)
A. fumigatus 1 (33.3)
Post renal transplant 1 1 (100) C. albicans 1 (100)
Pancytopenia 1 1 (100) C. albicans 1 (100)
Alcoholism 3 1 (33.3) C. albicans 1 (100)
Anaemia (Hb < 9%) 6 3 (50) C. albicans 2 (33.3)
A. niger 1 (16.7)
CRF 1 1 (100) C. albicans 1 (100)
Cirrhosis 1 1 (100) C. albicans 1 (100)
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prelude to the development of co-morbidity due to inva-
sive or disseminated fungal disease and if so, to work
out the time kinetics and nature of such progression.
However, none of our patients developed invasive fungal
infection till the completion of the study.
Though Candida sp.a n dAspergillus sp.c o n s t i t u t et h e
bulk of fungi reported in pulmonary mycoses, their rela-
tive proportion and species distribution have shown
considerable geographical variation. In the present
study, Candida albicans was the most frequent isolate,
being recovered from 42.9% of patients, followed by
Aspergillus flavus (21.4%), Aspergillus fumigatus (14.3%),
Aspergillus niger (10.7%), Candida tropicalis (7.1%) and
Cryptococcus neoformans (3.6%). In a similar study on
Candida infection in chronic pulmonary conditions,
Phukan et al. reported an isolation rate of 50% from
sputum specimens, with C. albicans and C. tropicalis
predominating [9]. In studies on pulmonary Aspergillo-
sis occurring in chronic lung diseases, Kurhade et al
[10] and Shahid et al [11] have reported isolation of the
fungus from 16.3% and 14.7% of cases of chronic
respiratory diseases, using sputum and BAL samples
respectively. The species distribution of Aspergillus
showed some difference between these studies and the
present study. Aspergillus fumigatus accounted for 80%
of the isolates in the former study and Shahid et al [11]
reported Aspergillus fumigatus as the predominant spe-
cies being isolated from 69.2% cases. Our findings are
consistent with reports from other centres in India, in
which isolation rate of A. flavus largely exceeded that of
A. fumigatus, underscoring the importance of geographi-
cal differences in fungal recovery [12].
The performance of serological tests in the diagnosis
of pulmonary mycoses is dependent on a number of fac-
tors including the choices of antigen and assay and the
immune status of patients. Discordant result between
culture and immunodiffusion assays was observed by us
in 18 of the 60 (30%) patients. Among them, immuno-
compromising conditions were observed in 8 of the
12 patients who were culture-positive but immunodiffu-
sion-negative. In view of the ubiquity of common fungi,
serological evidence has been reported to assist in con-
firming fungal infection and add to the clinical signifi-
cance of fungal recovery [13]. However, interpretation of
serological assays becomes difficult in the presence of
immunocompromised clinical status [10,14] and invasive
fungal infections [15]. In our study, 5 of the 6 patients
who were immunodiffusion-positive but culture-negative
had bronchogenic carcinoma. The sixth patient had
pleural effusion of unresolved aetiology, in whom the
possibility of bronchogenic carcinoma could not be
excluded. Fungal recovery may be difficult in broncho-
genic carcicoma because of non-communication of the
lesion with main bronchus [11] and might have been
improved in our study on including multiple specimens.
Similar observations have been reported by Malik et al
who found serology to be more sensitive than culture
for the detection of Aspergillosis in patients with
bronchogenic carcinoma [16]. We observed
Table 4 Association of different fungal isolates with radiological findings
Radiological finding No. of patients Culture +ve patients (%) Isolates No. of Isolates (%)
Consolidation 18 9 (50) C. albicans 5(27.8)
A. flavus 2(11.1)
A. fumigatus 2(11.1)
Collapse 9 4 (44.4) A. flavus 2(22.2)
A. fumigatus 1(11.1)
C. tropicalis 1(11.1)
Nodular lesion 8 2 (25) C. albicans 1(12.5)
A. niger 1(12.5)
Consolidation + Pleural effusion 5 3 (60) C. tropicalis 1(20)
A. flavus 1(20)
A. fumigatus 1(20)
Normal 10 5 (50) C. albicans 3(30)
A. flavus 1(10)
A. niger 1(10)
Pleural effusion 2 1 (50) A. niger 1(50)
Fibrotic change + Pleural thickness 3 1 (33.3) C. albicans 1(33.3)
Cavity 4 2 (50) C. albicans 2(50)
Reticulonodular lesion 1 1 (100) C. neoformans 1(100)
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patients, which is in broad agreement with figures
reported in similar studies [10,11,13,17,18].
Owing to the presence of pre-existing respiratory
pathology in the recruited patients, it is difficult to
establish a causal relationship between the culture-posi-
tivity and radiological abnormality. However, 50 of our
patients had radiological abnormalities in their chest
X-ray, of whom 23 patients were culture-positive for
fungal agents. On the other hand, 5 of our culture-posi-
tive patients had normal Chest X-ray. Bronchoscopic
examnation of all of these 5 patients revealed the pre-
sence of central tumors, which could account for the
normal appearance on chest X-ray.
In the present study, we report for the first time, sero-
logical evidence of Candidiasis in patients with chronic
respiratory diseases. Immunodiffusion test with cytoplas-
mic antigen of Candida albicans was positive in 12 of
the 60 patients (20%). Of them, 8 patients were culture-
positive for Candida and the remaining 4 patients were
culture-negative. Sero-reactivity to the 47 kD cytoplas-
mic antigen has been shown in previous studies to dis-
criminate between patients with deep-seated invasive
Candidiasis and superficial Candidiasis and has been
proved to be a valuable adjunct in the diagnosis of inva-
sive candidiasis [19,20]. In view of these findings, we
used the cytoplasmic antigen of Candida albicans in an
immunodiffusion format and detected precipitin antibo-
dies in 57.1% of our patients.
The point prevalence of fungal colonization was found
to be almost 50% in our patients. Since no association
was observed with clinical diagnosis, co-existing risk fac-
tors and radiological findings, it is imperative that the
possibility of accompanying fungal colonization should
be explored meticulously in such patients. An interest-
ing predilection was observed for Aspergillus sp.a n d
Candida sp. to preferentially infect patients with
Bronchoenic carcinoma and Tubercular sequelae respec-
tively. Till further evidence is generated to establish the
prognostic implications of fungal colonization with cer-
tainty, these patients should be closely monitored, in
order to enable earlier detection of invasive or dissemi-
nated fungal infection.
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